Aj. Eshleman et al., METABOLISM OF CATECHOLAMINES BY CATECHOL-O-METHYLTRANSFERASE IN CELLSEXPRESSING RECOMBINANT CATECHOLAMINE TRANSPORTERS, Journal of neurochemistry, 69(4), 1997, pp. 1459-1466
To determine if catechol-O-methyltransferase (COMT) metabolizes catech
olamines within cell lines used for heterologous expression of plasmal
emmal transporters and alters the measured characteristics of H-3-subs
trate transport, the uptake of monoamine transporter substrates was as
sessed in three cell lines (C6 glioma, L-M fibroblast, and HEK293 cell
s) that had been transfected with the recombinant human transporters,
Uptake and cellular retention of H-3-catecholamines was increased by u
p to fourfold by two COMT inhibitors, tropolone and Ro 41-0960, with p
otencies similar to those for inhibition of COMT activity, whereas the
uptake of two transporter substrates that are not substrates for COMT
, [H-3]serotonin and [H-3]MPP+, was unaffected. Direct measurement of
monoamine substrates by HPLC confirmed that tropolone (1 mM) increased
the retention of the catecholamines dopamine and norepinephrine, but
not the retention of serotonin in HEK293 cells, Saturation analysis of
the uptake of [H-3]dopamine by C6 cells expressing the dopamine trans
porter demonstrated that tropolone (1 mM) decreased the apparent K-m o
f transport from 0.61 mu M to 0.34 mu M without significantly altering
the maximal velocity of transport, These data suggest that endogenous
COMT activity in mammalian cells may alter neurotransmitter depositio
n and thus the apparent kinetic characteristics of transport.